融合癌蛋白与协同突变决定NUP98重排白血病的疾病表型
研究对177例NUP98重排白血病进行全基因组突变和转录分析,发现协同遗传改变与分化状态相关,即使共享同一NUP98融合亦然。CUT&RUN分析体外脐血CD34+细胞模型显示NUP98融合癌蛋白直接调控分化相关基因。RB1缺失与NUP98::KDM5A协同阻断终末分化,WT1移码突变改变分化倾向,且不同协同改变对menin抑制敏感性不同。
要点
- NUP98重排白血病中协同突变与分化状态相关,同一融合可对应不同表型。
- NUP98融合癌蛋白直接调控分化相关基因,如NUP98::KDM5A结合MEIS2或GFI1B。
- RB1或WT1改变与NUP98::KDM5A协同影响分化,并对menin抑制敏感性不同。
核心结论
- NUP98重排白血病的表型异质性由融合癌蛋白与协同遗传改变共同决定,分化状态影响menin依赖性及耐药机制。
研究设计与样本
- 对177例NUP98重排白血病进行全基因组突变和转录分析,并结合体外脐血CD34+细胞模型、CUT&RUN图谱和CRISPR/Cas9基因编辑。
主要发现
- 在共享同一NUP98融合的白血病中,协同改变与分化状态相关,如NUP98::KDM5A急性巨核细胞白血病伴RB1缺失或T-ALL伴NOTCH1突变。
- NUP98融合癌蛋白直接调控分化相关基因,如NUP98::KDM5A结合MEIS2或GFI1B促进巨核细胞分化。
- 患者样本中NUP98融合癌蛋白结合模式异质,可能受体细胞突变和分化状态影响。
- RB1缺失与NUP98::KDM5A协同阻断向血小板的终末分化并扩增巨核样细胞。
- WT1移码突变使分化偏向静息淋巴-髓系定向祖细胞和循环粒细胞-单核细胞祖细胞。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Leukemias with NUP98 rearrangements exhibit heterogeneous phenotypes such as acute myeloid leukemia, T-cell acute lymphoblastic leukemia (T-ALL), or myelodysplastic syndrome/neoplasms associated with fusion partners, whereas the mechanism responsible for this heterogeneity is poorly understood. Through genome-wide mutational and transcriptional analyses of 177 NUP98-rearranged leukemias, we show that cooperating alterations are associated with differentiation status even among leukemias sharing the same NUP98 fusions, such as NUP98::KDM5A acute megakaryocytic leukemia with RB1 loss or T-ALL with NOTCH1 mutations. CUT&RUN profiling of in vitro cord blood CD34+ cell (cbCD34) models of major NUP98 fusions revealed that NUP98-fusion oncoproteins (FOs) directly regulate differentiation-related genes contributing to the disease phenotypes, represented by NUP98::KDM5A binding to MEIS2 or GFI1B for megakaryocyte (MK) differentiation. In patient samples, NUP98-FO binding patterns are heterogeneous, potentially shaped by somatic mutations and differentiation status. Using cbCD34 models and CRISPR/Cas9 gene editing, we show that RB1 loss cooperates with NUP98::KDM5A by blocking terminal differentiation toward platelets and expanding MK-like cells, whereas WT1 frameshift mutations skew differentiation toward dormant lymphoid-myeloid primed progenitor cells and cycling granulocyte-monocyte progenitor cells, providing evidence for NUP98-rearranged leukemia phenotypes affected by cooperating alterations. NUP98::KDM5A cbCD34 models with RB1 or WT1 alterations have different sensitivities to menin inhibition, suggesting that cellular differentiation provides stage-specific menin dependencies and resistance mechanisms that can be leveraged for future treatment strategies for NUP98-rearranged leukemia.
引用
- Umeda M, Hiltenbrand R, Michmerhuizen NL, et al. Fusion oncoproteins and cooperating mutations define disease phenotypes in NUP98-rearranged leukemia. Blood. 2025. PMID: 40700635. doi:10.1182/blood.2025028993
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。